RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia ; volume:6 ; number:01 ; year:2015 ; pages:033-038
Journal of neurosciences in rural practice ; 6, Heft 01 (2015), 033-038
- Beteiligte Personen und Organisationen
-
Bawaskar, Himmatrao Saluba
Bawaskar, Parag Himmatrao
Bawaskar, Pramodini Himmatrao
- DOI
-
10.4103/0976-3147.143187
- URN
-
urn:nbn:de:101:1-2019111811164570941471
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
19.11.2025, 06:05 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bawaskar, Himmatrao Saluba
- Bawaskar, Parag Himmatrao
- Bawaskar, Pramodini Himmatrao
Ähnliche Objekte (12)
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer’s disease
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer’s disease
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer’s disease
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease